Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer

Antonella Daniele, A. F. Zito, G. Giannelli, R. Divella, M. Asselti, A. Mazzocca, A. Paradiso, M. Quaranta

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

The objective of this study was to evaluate the expression of MMP-2 and MMP-9 in sentinel lymph node and serum of breast cancer patients in order to evaluate their clinical significance and usefulness as diagnostic tumour markers. Expression of MMP-2 and MMP-9 was performed on sentinel lymph node by immunohistochemistry while gelatine zymography was used to determinate the serum expression. The association of gelatinases with clinicopathological features, were analysed. Metastatic and non-metastatic breast cancer patients and 34 healthy women were involved. Gelatinases expression were significantly higher in metastatic breast cancer in comparison to non-metastatic cancer and the control group both in the sentinel lymph node and serum. Results showed a statistically significant correlation between MMP-2 or MMP-9 and cancer familiality, MMP-9 and CA 153 levels, and MMP-9 and grading. This study suggests a clinical utility of these proteolytic markers in malignant tumour, growth, invasion and metastasis in breast cancer.

Original languageEnglish
Pages (from-to)3521-3527
Number of pages7
JournalAnticancer Research
Volume30
Issue number9
Publication statusPublished - 2010

Fingerprint

Matrix Metalloproteinase 2
Matrix Metalloproteinases
Breast Neoplasms
Serum
Gelatinases
Neoplasms
Tumor Biomarkers
Sentinel Lymph Node
Immunohistochemistry
Neoplasm Metastasis
Control Groups
Growth

Keywords

  • Breast cancer
  • Metastasis
  • MMP-2
  • MMP-9
  • Sentinel lymph node

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Daniele, A., Zito, A. F., Giannelli, G., Divella, R., Asselti, M., Mazzocca, A., ... Quaranta, M. (2010). Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer. Anticancer Research, 30(9), 3521-3527.

Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer. / Daniele, Antonella; Zito, A. F.; Giannelli, G.; Divella, R.; Asselti, M.; Mazzocca, A.; Paradiso, A.; Quaranta, M.

In: Anticancer Research, Vol. 30, No. 9, 2010, p. 3521-3527.

Research output: Contribution to journalArticle

Daniele, A, Zito, AF, Giannelli, G, Divella, R, Asselti, M, Mazzocca, A, Paradiso, A & Quaranta, M 2010, 'Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer', Anticancer Research, vol. 30, no. 9, pp. 3521-3527.
Daniele, Antonella ; Zito, A. F. ; Giannelli, G. ; Divella, R. ; Asselti, M. ; Mazzocca, A. ; Paradiso, A. ; Quaranta, M. / Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer. In: Anticancer Research. 2010 ; Vol. 30, No. 9. pp. 3521-3527.
@article{62a43c9c99f94311ba67008381215f96,
title = "Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer",
abstract = "The objective of this study was to evaluate the expression of MMP-2 and MMP-9 in sentinel lymph node and serum of breast cancer patients in order to evaluate their clinical significance and usefulness as diagnostic tumour markers. Expression of MMP-2 and MMP-9 was performed on sentinel lymph node by immunohistochemistry while gelatine zymography was used to determinate the serum expression. The association of gelatinases with clinicopathological features, were analysed. Metastatic and non-metastatic breast cancer patients and 34 healthy women were involved. Gelatinases expression were significantly higher in metastatic breast cancer in comparison to non-metastatic cancer and the control group both in the sentinel lymph node and serum. Results showed a statistically significant correlation between MMP-2 or MMP-9 and cancer familiality, MMP-9 and CA 153 levels, and MMP-9 and grading. This study suggests a clinical utility of these proteolytic markers in malignant tumour, growth, invasion and metastasis in breast cancer.",
keywords = "Breast cancer, Metastasis, MMP-2, MMP-9, Sentinel lymph node",
author = "Antonella Daniele and Zito, {A. F.} and G. Giannelli and R. Divella and M. Asselti and A. Mazzocca and A. Paradiso and M. Quaranta",
year = "2010",
language = "English",
volume = "30",
pages = "3521--3527",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "9",

}

TY - JOUR

T1 - Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer

AU - Daniele, Antonella

AU - Zito, A. F.

AU - Giannelli, G.

AU - Divella, R.

AU - Asselti, M.

AU - Mazzocca, A.

AU - Paradiso, A.

AU - Quaranta, M.

PY - 2010

Y1 - 2010

N2 - The objective of this study was to evaluate the expression of MMP-2 and MMP-9 in sentinel lymph node and serum of breast cancer patients in order to evaluate their clinical significance and usefulness as diagnostic tumour markers. Expression of MMP-2 and MMP-9 was performed on sentinel lymph node by immunohistochemistry while gelatine zymography was used to determinate the serum expression. The association of gelatinases with clinicopathological features, were analysed. Metastatic and non-metastatic breast cancer patients and 34 healthy women were involved. Gelatinases expression were significantly higher in metastatic breast cancer in comparison to non-metastatic cancer and the control group both in the sentinel lymph node and serum. Results showed a statistically significant correlation between MMP-2 or MMP-9 and cancer familiality, MMP-9 and CA 153 levels, and MMP-9 and grading. This study suggests a clinical utility of these proteolytic markers in malignant tumour, growth, invasion and metastasis in breast cancer.

AB - The objective of this study was to evaluate the expression of MMP-2 and MMP-9 in sentinel lymph node and serum of breast cancer patients in order to evaluate their clinical significance and usefulness as diagnostic tumour markers. Expression of MMP-2 and MMP-9 was performed on sentinel lymph node by immunohistochemistry while gelatine zymography was used to determinate the serum expression. The association of gelatinases with clinicopathological features, were analysed. Metastatic and non-metastatic breast cancer patients and 34 healthy women were involved. Gelatinases expression were significantly higher in metastatic breast cancer in comparison to non-metastatic cancer and the control group both in the sentinel lymph node and serum. Results showed a statistically significant correlation between MMP-2 or MMP-9 and cancer familiality, MMP-9 and CA 153 levels, and MMP-9 and grading. This study suggests a clinical utility of these proteolytic markers in malignant tumour, growth, invasion and metastasis in breast cancer.

KW - Breast cancer

KW - Metastasis

KW - MMP-2

KW - MMP-9

KW - Sentinel lymph node

UR - http://www.scopus.com/inward/record.url?scp=77958581976&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958581976&partnerID=8YFLogxK

M3 - Article

C2 - 20944132

AN - SCOPUS:77958581976

VL - 30

SP - 3521

EP - 3527

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 9

ER -